top of page
Press
Leen Kawas Discusses 3 Financial Issues Biotech Leaders Should Address in 2024
Leen Kawas discusses three financial issues biotech leaders should address in 2024.
Leen Kawas Details the Factors Behind High Drug Development Costs (and Presents Strategies to Address Them)
Leen Kawas details the factors behind high drug development costs, and presents strategies to address them.
Leen Kawas Details Key Strategies for Increasing Clinical Trials’ Success Rates
Leen Kawas details key strategies for increasing clinical trials' success rates.
Leen Kawas Profiles Biotechnology Firms’ Partnerships with Contract Research Organizations
Leen Kawas profiles biotechnology firms' partnerships with contract research organizations.
Dr. Leen Kawas Discusses the Power of Workplace Friendships: Building Stronger Teams and Enhancing Job Satisfaction
Dr. Leen Kawas discusses the power of workplace friendships: building stronger teams and enhancing job satisfaction.
Dr. Leen Kawas Discusses The U.S. Biotechnology Industry’s Changing Dynamics And Offers 5 Strategic Recommendations For 2025
Dr. Leen Kawas discusses the US biotechnology industry's changing dynamics and offers five strategic recommendations for 2025.
Dr. Leen Kawas Discusses AI’s Integration into the Drug Development Cycle
Dr. Leen Kawas discusses artificial intelligence's integration into the drug development cycle.
Dr. Leen Kawas Highlights Precision Medicine Developments and Discusses 5 Emerging Trends
Dr. Leen Kawas highlights precision medicine developments and discusses five emerging trends.
Dr. Leen Kawas Highlights 3 Key Biotechnology Company Culture Trends for 2024
Dr. Leen Kawas highlights three key biotechnology company culture trends for 2024.
Dr. Leen Kawas Shares Insights on Her Remarkable Biotechnology Career Journey
Leen Kawas shares insights on her remarkable biotech career journey.
Dr. Leen Kawas Highlights Young Leaders’ Positive Impacts and Discusses Leadership Diversity
Dr. Leen Kawas highlights young leaders' positive impacts and discusses leadership diversity.
Empowering Entrepreneurs with Leen Kawas, PhD
Recruitomics Consulting|4/2/2024 This week, we had an insightful conversation with Leen Kawas, PhD, Managing General Partner at Propel...
Biotech Innovator Leen Kawas: How Biomarkers Integrate with AI, Machine Learning Healthcare
Dr. Leen Kawas, managing general partner at Propel Bio Partners, illustrates how biomarkers work alongside AI and machine learning to...
Dr. Leen Kawas Shares Insights on Her Next-Level Entrepreneurial Journey
Traveling a high-level entrepreneurial path involves numerous challenges and rewards. The entrepreneur’s focus on innovation often...
Dr. Leen Kawas Highlights Alzheimer’s Diagnosis and Treatment Innovations
Dr. Leen Kawas, co-founder and managing general partner at Propel Bio Partners, discusses innovations within the Alzheimer’s care...
Dr. Leen Kawas Describes The Microbiome of Babies and Its Multigenerational Applications
Dr. Leen Kawas delves into the microbiome of babies, and ways in which key discoveries can be implemented across multigenerational ...
Dr. Leen Kawas Discusses How a Hybrid Work Model Can Offer Balance and Enhance Performance
As the biotechnology industry continues its rapid growth, firms must cultivate a highly skilled workforce dedicated to moving each ...
Dr. Leen Kawas details Blockchain technology’s growth: Beyond crypto and into healthcare
Dr. Leen Kawas highlights how Blockchain technology, typically associated with cryptocurrency, is utilized within the healthcare space....
Dr. Leen Kawas Presents Biotech Industry Updates, Discusses Propel Bio Partners’ Investment Criteria
United States biotechnology companies are currently engaged in an industry-wide regeneration. In February 2023, RBC Capital Markets...
Leen Kawas on Actionable Steps for Women in Biotech to Break the Glass Ceiling in Leadership
The glass ceiling has become a notorious metaphor in the press in recent years for the way that upward mobility of women and other...
bottom of page